Related Experiment Videos
[Bisphosphonate, a new therapy principle in diseases of bone metabolism]
1Abteilung Innere Medizin I, Endokrinologie und Stoffwechsel, Medizinische Universitätsklinik Heidelberg.
Medizinische Klinik (Munich, Germany : 1983)
|August 15, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Association between telemedicine use and diabetes risk factor assessment and control in a primary care network.
Journal of endocrinological investigation·2022
A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Determinants of imminent fracture risk in postmenopausal women with osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Risk of subsequent fracture after prior fracture among older women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
[75-year old female with progressive idiopathic lung fibrosis].
Medizinische Klinik (Munich, Germany : 1983)·2011
[Mesenterial lymphangiolipoma - a rare finding in an asymptomatic patient].
Medizinische Klinik (Munich, Germany : 1983)·2011
[Resistant hypertension despite nine different antihypertensive drugs?].
Medizinische Klinik (Munich, Germany : 1983)·2011
[From the design of use study to the assessment of the benefit: with or without pharmaceutical industry?].
Medizinische Klinik (Munich, Germany : 1983)·2011
[Memorandum III "methods for health services research", Part 1 [authors: H. Pfaff, G. Glaeske, E. A. M. Neugebauer, M. Schrappe] and Part 2 [authors: E. A. M. Neugebauer, A. Icks, M. Schrappe] of the Deutsches Netzwerk Versorgungsforschung e.V.: A summary].
Medizinische Klinik (Munich, Germany : 1983)·2011
[Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension].
Medizinische Klinik (Munich, Germany : 1983)·2011
Pharmacokinetics, mass balance, and metabolism of [14C]SPH3127 (sitokiren), a novel direct renin inhibitor in humans.
Frontiers in pharmacology·2026
Effect of Sodium C-Tetra(propyl)resorcin[4]tetrasulfonate (Na4PRA) on Antituberculosis Drugs as Seen by Diffusometry and NMR Spectroscopy.
International journal of molecular sciences·2026
Pharmacodynamics of Boronic Acids and Boronates.
Handbook of experimental pharmacology·2026
Transdermal buprenorphine in low-dose induction strategies for opioid use disorder: a case report and systematic review.
Journal of the Academy of Consultation-Liaison Psychiatry·2026